| 产品详情 |
| Edit |   |
|---|
| Product Name | JZL195 |
|---|
| Description | JZL195 is a potent dual inhibitor of Monoacylglycerol lipase (MAGL) (IC50 = 2 nM) and fatty acid amide hydrolase (FAAH) (IC50 = 4 nM), enzymes that degrade the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide (AEA), the endogenous ligands for the cannabinoid G-protein coupled receptors CB1 and CB2. It poorly inhibits neuropathy target esterase and ABHD6 and does not inhibit other brain serine hydrolases. JZL 195 displays time-dependent inhibition of FAAH and MAGL in vivo, consistent with a covalent mechanism of activation. MW: 433.46. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[(3-Phenoxyphenyl)methyl]-1-piper?azinecarboxylic acid 4-nitrophenyl ester |
|---|
| Gene, Accession, CAS # | CAS: 1210004-12-8 |
|---|
| Catalog # | B1064-5 |
|---|
| Price | |
|---|
| Order / More Info | JZL195 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|